That said, evidence-based oral approaches can produce meaningful change for many people and may come with fewer systemic side effects
JAMA Netw Open 7(8):e2427258e2427258 Miller MG, Terebuh P, Kaelber DC, Xu R, Davis PB (2024) Characterizing GLP-1 receptor agonist use in preadolescent and adolescent populations
Harlan Krumholz, a cardiologist and professor at the Yale School of Medicine
Safe Prescribing for People With G6PD Deficiency in the UK Good practice in the NHS is to record G6PD deficiency prominently in a patient's medical records and to enable prescribing alerts within clinical systems, so that clinicians are notified before potentially harmful medications are issued
CermakNMvan LoonLJ.The Use of carbohydrates during exercise as an ergogenic aid
LC-MS (ESI-MS): [ t R ] = 2 min, [M + H] + calcd